Literature DB >> 19854644

Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism.

Aiming Sun1, Yang J Lu, Haipeng Hu, Mamoru Shoji, Dennis C Liotta, James P Snyder.   

Abstract

A series of novel curcumin analogs, symmetrical dienones, were previously shown to possess cytotoxic, anti-angiogenic and anti-tumor activities. Analogs 1 (EF24) and 2 (EF31) share the dienone scaffold and serve as Michael acceptors. We propose that the anti-cancer effects of 1 and 2 are mediated in part by redox-mediated induction of apoptosis. In order to support this concept, 1 and 2 were treated with L-glutathione (GSH) and cysteine-containing dipeptides under mild conditions to form colorless water-soluble adducts, which were identified by LC/MS. Comparison of the cytotoxic action of 1, 2 and the corresponding conjugates, 1-(GSH)(2) and 2-(GSH)(2), illustrated that the two classes of compounds exhibit essentially identical cell killing capabilities. Compared with the yellow, somewhat light sensitive and nearly water insoluble compounds 1 and 2, the glutathione conjugates represent a promising new series of stable and soluble anti-tumor pro-drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854644      PMCID: PMC2791955          DOI: 10.1016/j.bmcl.2009.10.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

1.  Synthesis and use of a pseudo-cysteine for native chemical ligation.

Authors:  David A Alves; Dirk Esser; Robert J Broadbridge; Andrew P G Beevers; Christopher P Chapman; Clare E Winsor; Jason R Betley
Journal:  J Pept Sci       Date:  2003-04       Impact factor: 1.905

2.  Sulfur-containing polypeptides. XVIII. Unambiguous synthesis of the parallel and antiparallel isomers of some bis-cystine peptides.

Authors:  R G Hiskey; C Li; R R Vunnam
Journal:  J Org Chem       Date:  1975-12-12       Impact factor: 4.354

3.  A biomimetically inspired synthesis of the dehydropiperidine domain of thiostrepton.

Authors:  K C Nicolaou; Marta Nevalainen; Brian S Safina; Mark Zak; Stephan Bulat
Journal:  Angew Chem Int Ed Engl       Date:  2002-06-03       Impact factor: 15.336

4.  New methods for side-chain protection of cysteine.

Authors:  C W West; M A Estiarte; D H Rich
Journal:  Org Lett       Date:  2001-04-19       Impact factor: 6.005

5.  Human placenta sphingomyelinase, an exogenous acidic pH-optimum sphingomyelinase, induces oxidative stress, glutathione depletion, and apoptosis in rat hepatocytes.

Authors:  C García-Ruiz; M Marí; A Morales; A Colell; E Ardite; J C Fernández-Checa
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

6.  A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues.

Authors:  J R Dimmock; M P Padmanilayam; R N Puthucode; A J Nazarali; N L Motaganahalli; G A Zello; J W Quail; E O Oloo; H B Kraatz; J S Prisciak; T M Allen; C L Santos; J Balzarini; E De Clercq; E K Manavathu
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

7.  [The attempted synthesis of open-chain asymmetric cystine peptides by thio-induced fragmentation of sulfonyl thiocarbonates. Insulin fragments with intact disulfide bridges A20-B19].

Authors:  B Kamber
Journal:  Helv Chim Acta       Date:  1973-06-06       Impact factor: 2.164

8.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

Authors:  G Shoba; D Joy; T Joseph; M Majeed; R Rajendran; P S Srinivas
Journal:  Planta Med       Date:  1998-05       Impact factor: 3.352

9.  Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.

Authors:  Brian K Adams; Eva M Ferstl; Matthew C Davis; Marike Herold; Serdar Kurtkaya; Richard F Camalier; Melinda G Hollingshead; Gurmeet Kaur; Edward A Sausville; Frederick R Rickles; James P Snyder; Dennis C Liotta; Mamoru Shoji
Journal:  Bioorg Med Chem       Date:  2004-07-15       Impact factor: 3.641

10.  Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.

Authors:  Shishir Shishodia; Pravin Potdar; C Gary Gairola; Bharat B Aggarwal
Journal:  Carcinogenesis       Date:  2003-05-09       Impact factor: 4.944

View more
  20 in total

1.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

2.  Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993).

Authors:  Joel M Reid; Sarah A Buhrow; Judith A Gilbert; Lee Jia; Mamoru Shoji; James P Snyder; Matthew M Ames
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-24       Impact factor: 3.333

3.  Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).

Authors:  Pallavi Lagisetty; Dharmalingam Subramaniam; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Chem Biol Drug Des       Date:  2011-12-22       Impact factor: 2.817

4.  KSRP/FUBP2 Is a Binding Protein of GO-Y086, a Cytotoxic Curcumin Analogue.

Authors:  Hiroyuki Yamakoshi; Naoki Kanoh; Chieko Kudo; Atsuko Sato; Kazunori Ueda; Makoto Muroi; Shunsuke Kon; Masanobu Satake; Hisatsugu Ohori; Chikashi Ishioka; Yoshiteru Oshima; Hiroyuki Osada; Natsuko Chiba; Hiroyuki Shibata; Yoshiharu Iwabuchi
Journal:  ACS Med Chem Lett       Date:  2010-06-04       Impact factor: 4.345

5.  Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109.

Authors:  Terry W Moore; Shijun Zhu; Ryan Randolph; Mamoru Shoji; James P Snyder
Journal:  ACS Med Chem Lett       Date:  2014-01-10       Impact factor: 4.345

6.  Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.

Authors:  Anlys Olivera; Terry W Moore; Fang Hu; Andrew P Brown; Aiming Sun; Dennis C Liotta; James P Snyder; Younghyoun Yoon; Hyunsuk Shim; Adam I Marcus; Andrew H Miller; Thaddeus W W Pace
Journal:  Int Immunopharmacol       Date:  2011-12-22       Impact factor: 4.932

7.  Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.

Authors:  Paul A Jackson; John C Widen; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2016-12-20       Impact factor: 7.446

8.  Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro.

Authors:  Masayoshi Yamaguchi; Shijun Zhu; M Neale Weitzmann; James P Snyder; Mamoru Shoji
Journal:  Mol Cell Biochem       Date:  2014-11-22       Impact factor: 3.396

9.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

10.  Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.

Authors:  Andrew Brown; Qi Shi; Terry W Moore; Younghyoun Yoon; Andrew Prussia; Clinton Maddox; Dennis C Liotta; Hyunsuk Shim; James P Snyder
Journal:  J Med Chem       Date:  2013-04-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.